Japanese panel postpones verdict on Shionogi’s COVID pill until July

0

A health ministry panel on Wednesday postponed a decision on whether to grant emergency approval to Shionogi’s COVID-19 pill, citing the need for more discussion.

The oral drug, which is the first domestically developed COVID-19 treatment and is intended for use in patients with light to moderate symptoms, had been up for evaluation by the panel after the Osaka-based pharmaceutical company applied for approval under the emergency authorization system created in May.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)

Leave A Reply

Your email address will not be published.